KRAS and non-small cell lung carcinoma: Our results confirm that LCNECs harbor potentially targetable alterations in <i>KRAS</i>, <i>PIK3CA</i>, <i>RET</i>, <i>BRAF</i>, and <i>NTRK1</i>, albeit at lower frequencies than those typically observed in NSCLC.